Skip to main content
Công ty Cổ phần Dược phẩm Imexpharm logo

Công ty Cổ phần Dược phẩm Imexpharm — Investor Relations & Filings

Ticker · IMP ISIN · VN000000IMP0 HSX Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2022-03-07 Regulatory Filings
Country VN Viet Nam
Listing HSX IMP

About Công ty Cổ phần Dược phẩm Imexpharm

www.imexpharm.com

Imexpharm Corporation is a prominent pharmaceutical company with over 48 years of experience in the manufacturing, compounding, and distribution of high-quality pharmaceutical products. The company operates extensive production facilities, including three EU-GMP certified factory clusters and one WHO-GMP certified cluster, making it a leader in EU-GMP compliant manufacturing. Imexpharm is recognized as a top producer of antibiotics and offers a diverse product portfolio encompassing injectable and oral antibiotics, cardiovascular, ophthalmic, musculoskeletal, respiratory, and digestive system treatments, alongside vitamins, minerals, and health protection foods. With 28 product registrations for 11 products in Europe, Imexpharm is dedicated to delivering effective and safe healthcare solutions to the community.

Recent filings

Filing Released Lang Actions
IMP: Thông báo về ngày đăng ký cuối cùng tổ chức ĐHĐCĐ thường niên năm 2022
Regulatory Filings Classification · 75% confidence The document is a formal notice from the Ho Chi Minh Stock Exchange announcing the ex-rights trading date and record date for shareholders to attend the 2022 Annual General Meeting of Imexpharm (IMP). It sets out corporate action details (record date, ex-rights date, meeting content) rather than presenting financial statements, a management discussion, voting results, proxy materials, or an actual report. It does not fit categories like AGM materials (AGM-R), voting results (DVA), proxy statement (PSI), dividend notice (DIV), or any financial report type. Therefore, it should be classified under general regulatory announcements (RNS).
2022-03-07 Vietnamese
IMP: Nghị quyết HĐQT về việc chốt danh sách cổ đông tham dự ĐHĐCĐ thường niên năm 2022
Regulatory Filings Classification · 87% confidence The document is a mandatory 24-hour disclosure filed with the State Securities Commission and Ho Chi Minh Stock Exchange. It contains the Board of Directors’ resolution to set the AGM date and record date, not actual financial statements, proxy materials, or management changes. It is therefore a general regulatory announcement that does not fit more specific categories and should be classified as a Regulatory Filing (RNS).
2022-02-28 Vietnamese
IMP: Báo cáo về ngày không còn là cổ đông lớn KWE Beteiligungen AG
Major Shareholding Notification Classification · 95% confidence The document is a regulatory notice filed with the State Securities Commission and Ho Chi Minh Stock Exchange reporting that KWE Beteiligungen AG has ceased to be a major shareholder (crossed below the 5% threshold) of closed fund certificates for Imexpharm. It details pre- and post-transaction shareholdings, transaction date and volume. This matches a Major Shareholding Notification (changes in significant share ownership levels).
2022-02-15 Tagalog
IMP: Thông báo mua cổ phiếu phát hành tăng vốn điều lệ của Agimexpharm
Regulatory Filings Classification · 85% confidence The document is a Vietnamese regulatory disclosure to the State Securities Commission and HoSE announcing that Imexpharm has purchased 1,693,928 newly issued shares of another company (Agimexpharm) under a board resolution. It is an irregular corporate disclosure rather than a financial report (10-K, IR, ER, etc.), not a director’s insider trade (DIRS), not a share repurchase of its own shares (POS), and not a formal major takeover or financing prospectus. This falls under general regulatory filings for miscellaneous required announcements (RNS).
2022-02-14 Vietnamese
IMP: Giấy xác nhận về việc thay đổi nội dung đăng ký doanh nghiệp
Regulatory Filings Classification · 85% confidence The document is a corporate disclosure filed with the State Securities Commission and HOSE regarding a change in business registration contents, including an attached certificate from the Department of Planning and Investment. It is not an earnings release, financial report, management change, dividend notice, or other specific category but rather a general regulatory compliance announcement. This falls under the fallback category of Regulatory Filings (RNS).
2022-02-11 Vietnamese
IMP: Báo cáo kết quả giao dịch cổ phiếu của tổ chức có liên quan đến Người nội bộ SK Investment Vina III Pte. Ltd.
Director's Dealing Classification · 95% confidence The document is an insider trading disclosure detailing the share transactions of an internal person (a Board member) and affiliated persons, submitted to the State Securities Commission and stock exchange. This is a personal insider trading report by a director/executive. According to our taxonomy, this falls under Director's Dealing (Code: DIRS).
2022-02-11 Tagalog

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.